Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT02107651
Brief Summary:
Serious adverse events in patients treated with new oral anticoagulants are underreported.
Detailed Description:
The study investigates if serious adverse events in patients treated with NOAC are reported to the Health and Medicines Authority.
Study:
NCT02107651
Study Brief:
Protocol Section:
NCT02107651